Mohammad Alimohammadi
Overview
Explore the profile of Mohammad Alimohammadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lundquist P, Hagforsen E, Wagner M, Alimohammadi M, Melo F, Pejler G, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Dec;
1871(3):167634.
PMID: 39706352
Psoriasis is a chronic skin disease occasionally associated with abdominal symptoms and IBD. We aimed to characterize intestinal immune cells and the integrity of the intestinal barrier in psoriasis. Biopsies...
2.
Alimohammadi M, Furman-Assaf S, Nilsson J
Aesthet Surg J
. 2024 Jun;
44(11):1218-1226.
PMID: 38874166
Background: Hyaluronic acid dermal fillers are used for multiple indications, including wrinkle correction and restoration of volume/fullness. Objectives: The aim of this study was to compare the efficacy and safety...
3.
Keeping up appearances: Don't frown upon the effects of botulinum toxin injections in facial muscles
Punga A, Alimohammadi M, Liik M
Clin Neurophysiol Pract
. 2023 Sep;
8:169-173.
PMID: 37681120
Aesthetic use of low doses of Botulinum toxin (BoNT) injections into the facial muscles has become a leading non-surgical aesthetic treatment worldwide to reduce facial wrinkles, including glabellar lines, forehead...
4.
Landegren N, Ishii N, Aranda-Guillen M, Gunnarsson H, Sardh F, Hallgren A, et al.
Proc Natl Acad Sci U S A
. 2021 Dec;
118(51).
PMID: 34911754
Autoantigen discovery is a critical challenge for the understanding and diagnosis of autoimmune diseases. While autoantibody markers in current clinical use have been identified through studies focused on individual disorders,...
5.
Jenkins S, Alimohammadi M, Terry A, Griffin R, Tackett A, Leung J, et al.
Angiogenesis
. 2021 Feb;
24(3):597-611.
PMID: 33629198
Antibiotic-induced microbial imbalance, or dysbiosis, has systemic and long-lasting effects on the host and response to cancer therapies. However, the effects on tumor endothelial cells are largely unknown. Therefore, the...
6.
Mahmood M, Villagarcia H, Dervishi E, Mustafa T, Alimohammadi M, Casciano D, et al.
J Mater Chem B
. 2020 Apr;
1(25):3220-3230.
PMID: 32260922
In this work, we demonstrate that graphitic nanomaterials-carboxylated multi-walled carbon nanotubes (MWCNTs) and carboxylated graphenes (Gn)-have the ability to stimulate the process of osteogenesis in mammalian bone cells and significantly...
7.
McGehee D, Alimohammadi M, Khodakovskaya M
Nanotechnology
. 2019 Mar;
30(27):275102.
PMID: 30901766
Carbon-based nanomaterials (CBNs) were previously described as regulators of plant cell division. Here, we demonstrated the ability of multi-walled carbon nanotubes (MWCNT) and graphene to enhance biomass production in callus...
8.
Alimohammadi M, Punga A
Toxins (Basel)
. 2017 Oct;
9(11).
PMID: 29084148
Botulinum toxin (BoNT) injections into facial and bulbar muscles are widely and increasingly used as medical treatments for cervical and facial dystonia, facial hemispasm, correction of facial palsy, hyperhidrosis, as...
9.
Eriksson D, Dalin F, Eriksson G, Landegren N, Bianchi M, Hallgren A, et al.
J Clin Endocrinol Metab
. 2017 Oct;
103(1):179-186.
PMID: 29069385
Context: Autoimmune polyendocrine syndrome type 1 (APS1) is a monogenic disorder that features autoimmune Addison disease as a major component. Although APS1 accounts for only a small fraction of all...
10.
Smith-Anttila C, Bensing S, Alimohammadi M, Dalin F, Oscarson M, Zhang M, et al.
Autoimmunity
. 2017 May;
50(4):223-231.
PMID: 28557628
Autoimmune polyendocrine syndrome type 1 (APS1) is a rare monogenic autoimmune disorder caused by mutations in the autoimmune regulator (AIRE) gene. High titer autoantibodies are a characteristic feature of APS1...